These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 17085226)
21. Collagen substances. Klein AW Facial Plast Surg Clin North Am; 2001 May; 9(2):205-18, viii. PubMed ID: 11457687 [TBL] [Abstract][Full Text] [Related]
22. Electron microscopic documentation of late changes in permanent fillers and clinical management of granulomas in affected patients. Wiest LG; Stolz W; Schroeder JA Dermatol Surg; 2009 Oct; 35 Suppl 2():1681-8. PubMed ID: 19807764 [TBL] [Abstract][Full Text] [Related]
23. Complications in fillers and Botox. Niamtu J Oral Maxillofac Surg Clin North Am; 2009 Feb; 21(1):13-21, v. PubMed ID: 19185791 [TBL] [Abstract][Full Text] [Related]
24. A double-blind, clinical evaluation of facial augmentation treatments: a comparison of PRI 1, PRI 2, Zyplast and Perlane. Downie J; Mao Z; Rachel Lo TW; Barry S; Bock M; Siebert JP; Bowman A; Ayoub A J Plast Reconstr Aesthet Surg; 2009 Dec; 62(12):1636-43. PubMed ID: 18986859 [TBL] [Abstract][Full Text] [Related]
25. A double-blind, comparative study of nonanimal-stabilized hyaluronic acid versus human collagen for tissue augmentation of the dorsal hands. Man J; Rao J; Goldman M Dermatol Surg; 2008 Aug; 34(8):1026-31. PubMed ID: 18430173 [TBL] [Abstract][Full Text] [Related]
27. The utility of soft tissue fillers in clinical dermatology: treatment of fine wrinkles and skin defects. Sadick N; Sorhaindo L Expert Rev Med Devices; 2007 Jul; 4(4):559-65. PubMed ID: 17605691 [TBL] [Abstract][Full Text] [Related]
28. Semipermanent and permanent injectable fillers. Jones DH Dermatol Clin; 2009 Oct; 27(4):433-44, vi. PubMed ID: 19850193 [TBL] [Abstract][Full Text] [Related]
31. Hyaluronic acid skin fillers: adverse reactions and skin testing. Lowe NJ; Maxwell CA; Lowe P; Duick MG; Shah K J Am Acad Dermatol; 2001 Dec; 45(6):930-3. PubMed ID: 11712042 [TBL] [Abstract][Full Text] [Related]
32. Longevity of effects of injectable products for soft-tissue augmentation. Werschler WP; Weinkle S J Drugs Dermatol; 2005; 4(1):20-7. PubMed ID: 15696981 [TBL] [Abstract][Full Text] [Related]
33. New trends in face rejuvenation by hyaluronic acid injections. Andre P J Cosmet Dermatol; 2008 Dec; 7(4):251-8. PubMed ID: 19146600 [TBL] [Abstract][Full Text] [Related]
34. Breakthroughs in US dermal fillers for facial soft-tissue augmentation. Goldberg DJ J Cosmet Laser Ther; 2009 Dec; 11(4):240-7. PubMed ID: 19951196 [TBL] [Abstract][Full Text] [Related]
35. Perioral rejuvenation and lip augmentation. Ali MJ; Ende K; Maas CS Facial Plast Surg Clin North Am; 2007 Nov; 15(4):491-500, vii. PubMed ID: 18005890 [TBL] [Abstract][Full Text] [Related]
36. Hyaluronic acid fillers: Hylaform and Captique. Monheit GD Facial Plast Surg Clin North Am; 2007 Feb; 15(1):77-84, vii. PubMed ID: 17317558 [TBL] [Abstract][Full Text] [Related]
37. Survey of future injectables. Ellis DA; Makdessian AS; Brown DJ Facial Plast Surg Clin North Am; 2001 Aug; 9(3):405-11. PubMed ID: 11457704 [TBL] [Abstract][Full Text] [Related]
38. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Christensen LH Dermatol Surg; 2009 Oct; 35 Suppl 2():1612-9. PubMed ID: 19807755 [TBL] [Abstract][Full Text] [Related]
39. Injectable fillers: review of material and properties. Attenello NH; Maas CS Facial Plast Surg; 2015 Feb; 31(1):29-34. PubMed ID: 25763894 [TBL] [Abstract][Full Text] [Related]